Showing results (951-960 of 1,386) with videos related to
Sort By:
Pageof 139
Primary Care Diabetes|July 30, 2020
The prevalence of mental health medication use in a cohort of New Zealand patients with diabetesLynne Chepulis, Brittany Morison, Chunhuan Lao, et al.Primary Care Diabetes|August 10, 2020
Cardiometabolic risk factors in Venezuela. The EVESCAM study: a national cross-sectional survey in adultsRamfis Nieto-Martínez, Juan P González-Rivas, Eunice Ugel, et al.Primary Care Diabetes|July 23, 2020
Fatty liver index and risk of diabetes incidence: A systematic review and dose-response meta-analysis of cohort studiesMina Movahedian, Jamal Rahmani, Seyed Saeed Hashemi Nazari, et al.Primary Care Diabetes|June 19, 2014
Diabetes education and care in a developing country: observations from Karachi, PakistanMuhammad Adil Sheikh, Rubina Hakeem, Farzana Asar, et al.Primary Care Diabetes|May 21, 2014
Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countriesUgne Sabale, Mattias Ekman, Ola Granström, et al.Primary Care Diabetes|June 17, 2014
Diabetes care and complications in primary care in the Tshwane district of South AfricaElizabeth M Webb, Paul Rheeder, Danie G Van ZylPrimary Care Diabetes|June 24, 2014
Quality of diabetes care in family medicine practices in eastern Bosnia and HerzegovinaMaja Račić, Srebrenka Kusmuk, Srđan Mašić, et al.Primary Care Diabetes|July 4, 2020
Serum 25-hydroxyvitamin D is associated with insulin resistance independently of obesity in children ages 5-17Emrah Gün, Hakan Uzun, Semih Bolu, et al.Primary Care Diabetes|June 28, 2020
Multidisciplinary team approach to diabetes. An outlook on providers' and patients' perspectivesHon Qin Marcus Tan, Yip Han Chin, Cheng Han Ng, et al.Primary Care Diabetes|July 4, 2012
Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in GermanyKarel Kostev, Franz-Werner DippelPageof 139